Saxenda is the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management in adults
According to some reports, about one-third of patients achieved weight loss maintenance and lost about 10% of their body weight
Sermorelin stimulates the production and release of growth hormone by acting on the pituitary gland, while tesamorelin specifically targets and enhances growth hormone secretion
Pain, reflux, urination, and hot flashes can also fragment sleep
As we look ahead to the remainder of 2025 and into 2026, we have several efforts underway to address the increase in medical and pharmacy costs across Independence Health Group, including our work to transition from high-cost drugs, like Humira, to biosimilars, Lopez said
Others find that staying on maintenance doses prevents regain